Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form

Her2/neu status determination in breast cancer: a single institutional experience using a dual-testing approach with immunohistochemistry and fluorescence in situ hybridization

Academic Article
uri icon
  • Overview
  • Research
  • Identity
  • Additional Document Info
  • View All
scroll to property group menus

Overview

authors

  • Solomon, James Patrick
  • Dell'Aquila, M.
  • Fadare, O.
  • Hasteh, F.

publication date

  • April 2017

journal

  • American Journal of Clinical Pathology  Journal

subject areas

  • Aged
  • Biomarkers, Tumor
  • Breast Neoplasms
  • Carcinoma
  • Chromosomes, Human, Pair 17
  • Cohort Studies
  • Female
  • Genetic Testing
  • Humans
  • Immunohistochemistry
  • In Situ Hybridization, Fluorescence
  • Middle Aged
  • Neoplasm Staging
  • Receptor, ErbB-2
  • Retrospective Studies
scroll to property group menus

Research

keywords

  • Ancillary testing
  • Breast carcinoma
  • ERBB2
  • Fluorescence in situ hybridization
  • Her2/neu
scroll to property group menus

Identity

International Standard Serial Number (ISSN)

  • 0002-9173

Digital Object Identifier (DOI)

  • 10.1093/ajcp/aqw224

PubMed ID

  • 28340220
scroll to property group menus

Additional Document Info

start page

  • 432

end page

  • 437

volume

  • 147

issue

  • 4

©2021 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support